Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Dalton Transactions (Cambridge, England : 2003)|October 20, 2015
Rhenium complexes of bidentate, bis-bidentate and tridentate N-heterocyclic carbene ligandsChung Ying Chan, Peter J BarnardClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
PARP Inhibitors in Cancer Diagnosis and TherapyChung Ying Chan, Kel Vin Tan, Bart CornelissenInorganic Chemistry|October 4, 2014
Rhenium and technetium tricarbonyl complexes of N-heterocyclic carbene ligandsChung Ying Chan, Paul A Pellegrini, Ivan Greguric, et al.Journal of Inorganic Biochemistry|July 22, 2017
Copper-based reactions in analyte-responsive fluorescent probes for biological applicationsHo Yu Au-Yeung, Chung Ying Chan, Ka Yan Tong, et al.Organic Letters|August 30, 2021
Copper-Mediated Radiosynthesis of [18F]RucaparibZijun Chen, Gianluca Destro, Florian Guibbal, et al.Chemical Communications (Cambridge, England)|January 24, 2017
Rhenium(i) complexes of N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's diseaseChung Ying Chan, Asif Noor, Catriona A McLean, et al.Nuclear Medicine and Biology|January 9, 2023
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapyGianluca Destro, Zijun Chen, Chung Ying Chan, et al.Journal of Visualized Experiments : Jove|September 19, 2022
Non-invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular CarcinomaKel Vin Tan, Xinxiang Yang, Chung Ying Chan, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2022
Imaging PARP with [18F]rucaparib in pancreatic cancer modelsChung Ying Chan, Zijun Chen, Gianluca Destro, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of CancerChung Ying Chan, Zijun Chen, Florian Guibbal, et al.Pageof 2